-
公开(公告)号:US20190184056A1
公开(公告)日:2019-06-20
申请号:US15844450
申请日:2017-12-15
申请人: MANAR M. JAMAL
发明人: MANAR M. JAMAL
IPC分类号: A61L24/00 , A61L24/02 , A61L27/38 , A61L27/36 , A61L27/12 , A61L27/10 , A61L27/02 , A61L27/54 , A61L27/56 , A61L27/58 , A61L24/10 , A61L27/24 , A61C13/15 , A61F2/28 , A61C8/02
CPC分类号: A61L24/0036 , A61C8/0006 , A61C19/003 , A61F2/2857 , A61F2002/2835 , A61F2002/3093 , A61F2250/0081 , A61L24/0005 , A61L24/0015 , A61L24/0042 , A61L24/02 , A61L24/102 , A61L27/025 , A61L27/10 , A61L27/12 , A61L27/24 , A61L27/3608 , A61L27/365 , A61L27/3821 , A61L27/3834 , A61L27/3847 , A61L27/54 , A61L27/56 , A61L27/58 , A61L2300/414 , A61L2300/604 , A61L2300/64 , A61L2430/02 , A61L2430/12 , A61L2430/34
摘要: A method comprising the steps of applying an adhesive composition to a substrate bone repair region. The adhesive composition comprises a porous, biocompatible, biodegradable, resorbable, non-toxic, and polymerizable composition. The substrate bone repair region comprises a bone structure, implant or device surface, or tooth surface. The adhesive composition is cured to provide a polymerized adhesive composition resulting in repairing or augmenting the substrate bone repair region. The adhesive composition may be mixed with a bone graft material before application. The adhesive composition may be additionally applied to a barrier membrane that is placed over the substrate bone repair region where the adhesive composition or combination of adhesive composition and bone graft material is applied.
-
公开(公告)号:US09999703B2
公开(公告)日:2018-06-19
申请号:US14980254
申请日:2015-12-28
发明人: Kristian Larsen
IPC分类号: A61K38/48 , A61K9/19 , A61K31/047 , A61L26/00 , A61K31/70 , A61K9/16 , A61K38/01 , A61L24/00 , A61L24/10 , A61L2/04 , A61L2/08 , A61L2/10 , A61L2/20 , B65B1/04 , B65D81/32 , A61L2/07
CPC分类号: A61L26/0047 , A61K9/1658 , A61K31/047 , A61K31/70 , A61K38/014 , A61L2/04 , A61L2/07 , A61L2/081 , A61L2/082 , A61L2/087 , A61L2/10 , A61L2/202 , A61L2/204 , A61L2/206 , A61L2/208 , A61L24/0015 , A61L24/0036 , A61L24/104 , A61L26/00 , A61L26/0038 , A61L26/0066 , A61L2300/254 , A61L2300/418 , A61L2300/802 , A61L2400/04 , A61L2400/06 , B65B1/04 , B65D81/32
摘要: The present invention relates to a dry composition, which upon addition of an aqueous medium forms a substantially homogenous paste suitable for use in haemostasis procedures. The paste forms spontaneously upon addition of the liquid, hence no mechanical mixing is required for said paste to form. The invention further relates to methods of preparing said dry composition, a paste made from said dry composition and use of said paste for medical and surgical purposes.
-
公开(公告)号:US09931435B2
公开(公告)日:2018-04-03
申请号:US15137188
申请日:2016-04-25
IPC分类号: A61K9/70 , A61L27/24 , A61K9/00 , A61K9/16 , A61L27/58 , A61L24/00 , A61L24/10 , A61L27/46 , A61F2/02 , A61L24/02 , A61L27/02 , A61L27/54 , A61L27/56
CPC分类号: A61L27/24 , A61F2/02 , A61K9/0019 , A61K9/0024 , A61K9/1652 , A61L24/0015 , A61L24/0036 , A61L24/0042 , A61L24/0084 , A61L24/02 , A61L24/10 , A61L24/102 , A61L27/02 , A61L27/46 , A61L27/54 , A61L27/56 , A61L27/58 , A61L2300/112 , A61L2300/252 , A61L2300/412 , A61L2300/414 , A61L2300/45 , A61L2300/604 , A61L2400/06 , A61L2430/02 , A61L2430/38
摘要: Described is a medically useful article comprising a three-dimensional body including one or more implantable substances, wherein the body defines one or more reservoirs for receiving amounts of a biocompatible wetting liquid. In certain embodiments the body is disruptable upon wetting with the biocompatible liquid to form a conformable implantable material such as a putty, paste or more flowable wetted implant material. Also described are methods for manufacturing such medical materials, and methods for using such medical materials to treat patients.
-
公开(公告)号:US09931429B2
公开(公告)日:2018-04-03
申请号:US14643992
申请日:2015-03-10
CPC分类号: A61L24/02 , A61B18/18 , A61K9/14 , A61K9/1635 , A61K9/1652 , A61K49/0452 , A61K51/1244 , A61L24/0015 , A61L24/0036 , A61L24/0089 , A61L2300/102 , A61L2300/418 , A61L2300/606 , A61L2400/04 , A61L2430/36
摘要: A particle includes a ferromagnetic material, a radiopaque material, and/or an MRI-visible material.
-
公开(公告)号:US20170312385A1
公开(公告)日:2017-11-02
申请号:US15497720
申请日:2017-04-26
发明人: Edward S. AHN , Chia-En LIN , Colin D. WHITE
CPC分类号: A61L27/20 , A61B17/3472 , A61B17/8816 , A61B17/8825 , A61B17/8833 , A61B2017/00893 , A61B2017/8838 , A61L24/0031 , A61L24/0036 , A61L24/0042 , A61L24/0084 , A61L27/025 , A61L27/12 , A61L27/46 , A61L27/50 , A61L27/52 , A61L27/56 , A61L27/58 , A61L2400/06 , A61L2430/02 , C08L5/08
摘要: The present disclosure relates to methods and compositions for the treatment of degenerate bone in a patient. In some embodiments, the methods and compositions disclosed herein are useful in the treatment, prevention, or in delaying the progression of a bone disease linked to bone degeneration, such as osteoarthritis (“OA”), rheumatoid arthritis, and avascular necrosis.
-
公开(公告)号:US20170224381A1
公开(公告)日:2017-08-10
申请号:US15477890
申请日:2017-04-03
申请人: KCI Licensing, Inc.
CPC分类号: A61B17/56 , A61B17/88 , A61B2017/00004 , A61B2017/00544 , A61B2017/564 , A61F2/30721 , A61F2002/2835 , A61F2002/30754 , A61L24/0015 , A61L24/0036 , A61L2400/18
摘要: A system for applying a treatment to a defect in one bone of two bones forming a joint that comprises a bladder for delivering a reduced pressure to the defect and for providing a positive pressure as bracing between the two bones of the joint is disclosed. A method for applying such treatment is also disclosed. A bladder for applying such treatment that comprises a reduced-pressure chamber and a bracing chamber is also disclosed.
-
公开(公告)号:US09687501B2
公开(公告)日:2017-06-27
申请号:US13894396
申请日:2013-05-14
申请人: Xin Ji , Cheng Xing , Xueshen Shi , Jianping Chen
发明人: Xin Ji , Cheng Xing , Xueshen Shi , Jianping Chen
IPC分类号: A61K31/718 , A61L24/00 , A61L26/00 , A61K9/14 , C08L3/18 , C08L3/04 , C08L89/06 , C08B31/12 , C08B31/08 , C08B31/02 , C08B33/04 , C08B31/10 , C08B31/16 , C08B35/02 , C08B33/06 , C08B35/06 , C08B35/04 , C08B33/02 , C08B31/04 , C08B30/20 , C08B31/00 , C08B30/00 , A61K31/738 , A61L24/08 , A61K45/06 , A61K9/19 , C08B31/06 , A61K9/00
CPC分类号: A61L31/042 , A61K9/0014 , A61K9/14 , A61K9/19 , A61K31/718 , A61K31/738 , A61K45/06 , A61L24/0015 , A61L24/0036 , A61L24/0073 , A61L24/08 , A61L24/104 , A61L26/0023 , A61L26/0085 , A61L31/045 , A61L31/125 , A61L2300/406 , A61L2400/04 , A61L2430/34 , C08B30/00 , C08B30/20 , C08B31/00 , C08B31/003 , C08B31/02 , C08B31/04 , C08B31/08 , C08B31/10 , C08B31/12 , C08B31/16 , C08B33/02 , C08B33/04 , C08B33/06 , C08B35/02 , C08B35/04 , C08B35/06 , C08L3/04 , C08L3/18 , C08L89/06 , Y10T428/2982
摘要: A modified starch material is arranged for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.
-
公开(公告)号:US20170136144A1
公开(公告)日:2017-05-18
申请号:US15349806
申请日:2016-11-11
CPC分类号: A61L24/06 , A61B8/0833 , A61B8/0841 , A61B8/085 , A61B8/0891 , A61B8/481 , A61B8/488 , A61B17/12 , A61B17/12022 , A61B17/12186 , A61B17/3403 , A61B17/42 , A61B2017/3413 , A61F6/22 , A61K49/223 , A61K49/226 , A61L24/001 , A61L24/0015 , A61L24/0031 , A61L24/0036 , A61L27/52 , A61L27/54 , A61L2300/626 , A61L2400/06 , A61L2430/36
摘要: Disclosed are methods of delivering an agent to the lumen of the vas deferens under guidance of ultrasound imaging. The methods include vas-occlusive contraception in which the vas deferens is non-surgically isolated and an occlusive substance is percutaneously administered into the lumen of the vas deferens under ultrasound. Also disclosed are methods of reversal of vas-occlusive contraception and methods of delivering an agent to the lumen of the vas deferens. Also disclosed are compositions for use in the methods of the invention.
-
公开(公告)号:US09642931B2
公开(公告)日:2017-05-09
申请号:US14222271
申请日:2014-03-21
申请人: KCI Licensing, Inc.
CPC分类号: A61B17/56 , A61B17/88 , A61B2017/00004 , A61B2017/00544 , A61B2017/564 , A61F2/30721 , A61F2002/2835 , A61F2002/30754 , A61L24/0015 , A61L24/0036 , A61L2400/18
摘要: A system for applying a treatment to a defect in one bone of two bones forming a joint that comprises a bladder for delivering a reduced pressure to the defect and for providing a positive pressure as bracing between the two bones of the joint is disclosed. A method for applying such treatment is also disclosed. A bladder for applying such treatment that comprises a reduced-pressure chamber and a bracing chamber is also disclosed.
-
公开(公告)号:US09623143B2
公开(公告)日:2017-04-18
申请号:US14215988
申请日:2014-03-17
申请人: Gregory T. Zugates , Adam Rago , Toby Freyman , Upma Sharma , Rany Busold , John Caulkins , Parisa Zamiri , Jennifer Mortensen , Meghan McGill , Daniel K. Bonner
发明人: Gregory T. Zugates , Adam Rago , Toby Freyman , Upma Sharma , Rany Busold , John Caulkins , Parisa Zamiri , Jennifer Mortensen , Meghan McGill , Daniel K. Bonner
CPC分类号: A61L24/0015 , A61L24/0036 , A61L24/046 , A61L27/14 , A61L27/56 , A61L31/04 , A61L31/146 , A61L2300/418 , A61L2400/04 , A61L2430/22 , C08L75/04
摘要: The present invention relates generally to systems and methods and systems for generating polymer foams within body cavities to locate and/or control bleeding. The present invention further relates to methods and systems for generating polymer foams within non-compressible wounds to control or stop bleeding. The present invention further relates to the use of foams and gels for medical and cosmetic purposes.
-
-
-
-
-
-
-
-
-